Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes. (Q50759104)
Jump to navigation
Jump to search
scientific article published on 9 January 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes. |
scientific article published on 9 January 2015 |
Statements
1 reference
Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes. (English)
1 reference
1 reference
Aixin Yu
1 reference
Isaac Snowhite
1 reference
Francesco Vendrame
1 reference
Alberto Pugliese
1 reference
Thomas R Malek
1 reference
9 January 2015
1 reference
1 reference
64
1 reference
6
1 reference
2172-2183
1 reference
Identifiers
1 reference
1 reference